UTHR - UNITED THERAPEUTICS Corp

QQQ $ 476.50 $ 0.53 (0.11 %)

DIA $ 417.33 $ 2.44 (0.59 %)

SPY $ 562.48 $ 0.83 (0.15 %)

TLT $ 101.35 $ -0.04 (-0.04 %)

GLD $ 238.61 $ -0.02 (-0.01 %)

Previous Close

$ 344.98

Open

Bid

$ 344.71 x 200

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 208.62 - $ 366.08

Volume

393,757

Average Volume

Market Cap

15.35B

Beta (5Y Monthly)

$ 0.52

PE Ratio (TTM)

$ 14.35

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-31-2024	06-30-2024	10-Q
2	05-01-2024	03-31-2024	10-Q
3	02-21-2024	12-31-2023	10-K
4	11-01-2023	09-30-2023	10-Q
5	08-02-2023	06-30-2023	10-Q
6	05-03-2023	03-31-2023	10-Q
7	02-22-2023	12-31-2022	10-K
8	11-02-2022	09-30-2022	10-Q
9	08-03-2022	06-30-2022	10-Q
10	05-04-2022	03-31-2022	10-Q
11	02-24-2022	12-31-2021	10-K
12	11-03-2021	09-30-2021	10-Q
13	08-04-2021	06-30-2021	10-Q
14	05-05-2021	03-31-2021	10-Q
15	02-24-2021	12-31-2020	10-K
16	10-28-2020	09-30-2020	10-Q
17	07-29-2020	06-30-2020	10-Q
18	04-29-2020	03-31-2020	10-Q
19	02-26-2020	12-31-2019	10-K
20	10-30-2019	09-30-2019	10-Q
21	07-31-2019	06-30-2019	10-Q
22	05-01-2019	03-31-2019	10-Q
23	02-27-2019	12-31-2018	10-K
24	10-31-2018	09-30-2018	10-Q
25	08-01-2018	06-30-2018	10-Q
26	05-02-2018	03-31-2018	10-Q
27	02-21-2018	12-31-2017	10-K
28	10-25-2017	09-30-2017	10-Q
29	07-27-2017	06-30-2017	10-Q
30	04-26-2017	03-31-2017	10-Q
31	02-22-2017	12-31-2016	10-K
32	10-27-2016	09-30-2016	10-Q
33	07-28-2016	06-30-2016	10-Q
34	04-28-2016	03-31-2016	10-Q
35	02-25-2016	12-31-2015	10-K
36	10-27-2015	09-30-2015	10-Q
37	07-28-2015	06-30-2015	10-Q
38	04-28-2015	03-31-2015	10-Q
39	02-24-2015	12-31-2014	10-K
40	10-28-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Court Finds United Therapeutics' Interfere...
09/16/2024 13:43:32

Liquidia Corporation (NASDAQ:LQDA) (Liquidia), a biopharmaceutical company developing innovative therapies for patients with ra...

fda-battles-backlog-of-drug-factory-inspections-since-covid-19

FDA Battles Backlog of Drug Factory Inspec...
09/06/2024 15:52:51

FDA faces inspection backlog with serious public health implications, as critical drug manufacturing plants remain unchecked.

ambarella-to-rally-around-61-here-are-10-top-analyst-forecasts-for-wednesday

Ambarella To Rally Around 61%? Here Are 10...
08/28/2024 13:16:17

Oppenheimer Maintains Outperform on United...
08/28/2024 12:57:59

Oppenheimer analyst Hartaj Singh maintains United Therapeutics (NASDAQ:UTHR) with a Outperform and raises the price target f...

The Analyst Verdict: United Therapeutics I...
08/20/2024 17:00:39

Wells Fargo Maintains Overweight on United...
08/20/2024 16:21:51

Wells Fargo analyst Tiago Fauth maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and raises the price target fr...

nsa-code-breaker-jim-simons-hedge-fund-renaissance-technologies--ozempic-wegovy-maker-novo-nordisk-along-with-nvidia-palantir-among-top-holdings

NSA Code Breaker Jim Simons' Hedge Fund Re...
08/20/2024 02:25:30

Renaissance Technologies, the hedge fund founded by legendary mathematician and former NSA code breaker Jim Simons, recently di...

zim-integrated-shipping-services-posts-upbeat-earnings-joins-fubotv-foghorn-therapeutics-and-other-big-stocks-moving-higher-on-monday

ZIM Integrated Shipping Services Posts Upb...
08/19/2024 14:25:31

rivian-chipotle-mexican-and-sirius-xm-are-among-top-10-large-cap-losers-last-week-aug-11-aug-17-are-the-others-in-your-portfolio

Rivian, Chipotle Mexican And Sirius XM Are...
08/18/2024 17:06:46

Ten large-cap stocks were the worst performers last week, with TME, MBLY, RIVN, CMG, LINE, SIRI, HSY, BAX, BR, and UTHR all see...

Soros Fund Management Q2 2024 13F Shows Ex...
08/14/2024 20:34:13

Watching Liquidia; Traders Circulate Uncon...
08/13/2024 18:24:14

100-invested-in-this-stock-10-years-ago-would-be-worth-400-today

$100 Invested In This Stock 10 Years Ago W...
08/05/2024 19:00:15

HC Wainwright & Co. Reiterates Buy on Unit...
08/01/2024 13:08:50

HC Wainwright & Co. analyst Andrew Fein reiterates United Therapeutics (NASDAQ:UTHR) with a Buy and maintains $400 price...

B of A Securities Maintains Underperform o...
08/01/2024 11:28:15

B of A Securities analyst Greg Harrison maintains United Therapeutics (NASDAQ:UTHR) with a Underperform and lowers the price...

United Therapeutics Q2 2024 GAAP EPS $5.85...
07/31/2024 10:46:37

Navigating 9 Analyst Ratings For United Th...
07/25/2024 13:00:23

HC Wainwright & Co. Maintains Buy on Unite...
07/25/2024 10:27:47

HC Wainwright & Co. analyst Andrew Fein maintains United Therapeutics (NASDAQ:UTHR) with a Buy and raises the price targ...

heres-how-much-1000-invested-in-united-therapeutics-5-years-ago-would-be-worth-today

Here's How Much $1000 Invested In United T...
07/22/2024 21:30:23

if-you-invested-1000-in-this-stock-20-years-ago-you-would-have-28000-today

If You Invested $1000 In This Stock 20 Yea...
07/16/2024 14:30:54

TD Cowen Maintains Buy on United Therapeut...
07/11/2024 11:55:42

TD Cowen analyst Joseph Thome maintains United Therapeutics (NASDAQ:UTHR) with a Buy and raises the price target from $270 t...